CURRENT AFFAIRS

NEWS

31/10/2019

Marathon Boosts 43 Cancer Projects in Annual Largest Investment in Research in its History

Yesterday, October 30, diplomas were awarded to the 96 cancer research teams, which will receive the 15 million euros raised by the Marathon TV3 and Catalonia Radio 2018. This year Sant Pau had the honour of making public thanks through Dr. Virtudes Céspedes, coordinator of the Gynaecological and Peritoneal Oncology research group of the Sant Pau Research Institute – IIB Sant Pau.

The following research groups (https://www.ccma.cat/tv3/marato/projectes-financats/2018/1630/), including two from Sant Pau, will receive grants:

“Genomic indicators for the prediction of recurrence and metastasis in endometrial cancer”

Dr. María Virtudes Céspedes Navarro, Gynaecological and Peritoneal Oncology Research Group, Sant Pau Research Institute – IIB Sant Pau.

 “Humanized Nanomedicine selectively targeted to kill tumor cells CXCR4 + for the treatment of Acute Myeloid Leukemia”

Dr. Jordi Sierra, Oncological Hematology and Transplant Research Group. Hospital de la Santa Creu i Sant Pau- IRHSCSP Research Institute of the Hospital de la Santa Creu i Sant Pau.

 

The largest investment in research in the history of the Foundation

The 15 million euros raised in the 2018 edition of the Marathon allow the Foundation to make the largest annual investment in research in history. The 96 winning teams will work over the next three years to find more answers to cancer, a disease that, despite the great advances made in recent years, continues to have a very high incidence: one in two men and one in three women will have throughout their lives. The 43 awarded projects, in accordance with the decision of the Board of Trustees and at the proposal of the Scientific Advisory Committee, are the most highly rated of the 192 candidates submitted to the call for grants. The Catalan Agency for Healthcare Quality and Evaluation, Aqua, of the Department of Health, coordinated an international evaluation process in which 149 cancer experts assessed the work in terms of its quality and methodology, scientific, health and social relevance, and innovative value, among others. In 2024, the Foundation will announce the results obtained in the research work in a scientific symposium.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information